Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic serum micro eye drops versus conventional-sized serum eye drops
NL-OMON44587Active, not recruiting
- Sponsor
- Sanquin
- Start
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of allogenic serum, sponsored by Sanquin. Started Dec 2018; status: active, not recruiting.
02
Drugs
allogenic serum
Beyond the preview
Go deeper on NL-OMON44587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44587.